Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer02:18

Cancer

55.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stability of Classification Systems for Irritable Bowel Syndrome.

Alimentary pharmacology & therapeutics·2025
Same author

From Evidence to Practice: Quilting for Seroma Prevention After Mastectomy and Surgeons' Acceptance.

Cureus·2025
Same author

Deep phenotyping of patient lived experience in functional bowel disorders using machine learning.

Scientific reports·2025
Same author

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom.

Alimentary pharmacology & therapeutics·2025
Same author

Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel Syndrome.

Neurogastroenterology and motility·2025
Same author

Quality and readability of online information and materials on post-surgery breast seroma.

British journal of hospital medicine (London, England : 2005)·2024
Same journal

Characterization of a single liver cystic mass: a metastasis of squamous cell carcinoma of the nasopharynx.

International journal of surgery case reports·2026
Same journal

Open repair of infrarenal abdominal aortic aneurysm in a renal transplant recipient using extra-anatomic bypass: a case report.

International journal of surgery case reports·2026
Same journal

Therapeutic response to neoadjuvant chemotherapy in HER2-positive pure mucinous breast cancer: a case report.

International journal of surgery case reports·2026
Same journal

Upper limb mucormycosis in a patient with acute lymphoblastic leukemia: a case report.

International journal of surgery case reports·2026
Same journal

Mesenteric desmoid tumor with diagnostic challenge mimicking a malignant small intestinal tumor: a case report.

International journal of surgery case reports·2026
Same journal

Neonatal torsion of the vermiform appendix presenting as generalized peritonitis: a case report of a 10-day-old infant.

International journal of surgery case reports·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.1K

Atypical breasts cancers.

Lucie Wright1, Cho Ee Ng1, Tarannum Fasih1

  • 1Surgical Department, Queen Elizabeth Hospital, Gateshead, NE9 6SX, United Kingdom.

International Journal of Surgery Case Reports
|January 27, 2016
PubMed
Summary
This summary is machine-generated.

This study reviews rare breast cancer diagnoses and management strategies. It emphasizes evidence-based approaches for atypical breast malignancies to improve patient outcomes.

Keywords:
Apocrine carcinomaMalignant myoepitheliomaMucinous carcinomaRare breast malignancies

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.3K
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K

Related Experiment Videos

Last Updated: Mar 26, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.1K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.3K
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Increasing incidence of rare breast cancers presents diagnostic and management challenges.
  • Atypical breast malignancies require tailored strategies beyond standard protocols.
  • Breast Multi-Disciplinary Teams (MDT) face dilemmas in managing these unusual cases.

Purpose of the Study:

  • To discuss an evidence-based approach for managing rare breast malignancies.
  • To highlight the importance of accurate diagnosis in treatment and prognosis.
  • To review cases from a single breast screening unit.

Main Methods:

  • Retrospective review of patients with unusual breast malignancies (excluding invasive ductal and lobular carcinoma) treated between 2011-2015.
  • Histology and management of identified cases were analyzed.
  • Literature search using PubMed, Google, and Google Scholar focused on diagnosis, management, and prognosis of rare breast cancers.

Main Results:

  • Identification of patients with rare breast malignancies.
  • Review of diagnostic and management pathways for these cases.
  • Synthesis of literature to support evidence-based recommendations.

Conclusions:

  • Accurate diagnosis is critical for effective treatment and improved prognosis of rare breast cancers.
  • An evidence-based approach is essential for managing atypical breast malignancies.
  • This series provides insights into the management of rare breast cancers identified in a screening population.